Elsevier,

The Lancet Psychiatry, Available online 24 August 2023

This insight asserts the right of someone who has had an episode of mental illness to return to their previous employment
Elsevier,

The Lancet Psychiatry, Available online 22 August 2023

The commentary offers a proposal to aid the meaningful contribution of all voices in youth mental health research.
The article emphasizes the importance of providing training and supporting resources alongside open science initiatives to enhance accessibility and reduce barriers in the field. It suggests that these educational resources should be customized to cater to diverse user profiles, including neuroscientists, computational scientists, and educators.
Understanding the health of the mother can improve the health of the child.
This Article supports SDGs 3 and 10 by showing that in Austria, Greece, Spain, and the UK, there is a dearth of targeted, tailored cancer prevention programmes for people experiencing homelessness, and concern from health professionals that cancer is not being spotted at early stages in this population.
This Health Policy paper supports SDGs 3, 15, and 17, among others, by exploring the potential values and risks of establishing an Intergovernmental Panel for One Health (IPOH), with the aim of contributing to addressing other global challenges, such as food and water safety and environmental degradation in the context of One Health.
The study evaluates the use of nanocellulose as a food additive which is obtained from banana.
This Article supports Sustainable Development Goal 3 by showing that although there was an increase in prescribing of antipsychotics to people with dementia during the COVID-19 pandemic, this increase was not responsible for the large increase in all-cause and stroke mortality in this population.
This Article supports Sustainable Development Goal 3 by advancing our understanding of the possible role of active immunotherapy against amyloid-β in individuals with mild Alzheimer's disease; the findings of this phase 2a study support the continued clinical development of UB-311 as an active immunotherapy for Alzheimer's disease.

Pages